SCHEMBL5167569

SCHEMBL5167569

FC(F)(F)c1ccc(CSCCCBr)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 4/20 0.46
MAPT P10636 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
DAO P14920 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
PTPN1 P18031 1/20 0.37
GSK3B P49841 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
MAOB P27338 1/20 0.36
ACE P12821 1/20 0.36
ALOX15B O15296 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5167680 0.82 TAAR1 (0.53) IDO1MAPTTAAR1BCHEACHE
SCHEMBL23927282 0.80 IDO1 (0.59) IDO1MAPTTAAR1BCHEACHE
SCHEMBL5169242 0.78 IDO1 (0.42) IDO1MAPTTAAR1BCHEACHE
SCHEMBL7531508 0.78 IDO1 (0.49) IDO1MAPTTAAR1BCHEACHE
SCHEMBL4740642 0.76 CYP1A2 (0.44) IDO1MAPTL3MBTL1ALDH1A1
SCHEMBL79100 0.75 TAAR1 (0.57) IDO1TAAR1DAOSIRT2PTPN1
SCHEMBL6042549 0.75 CYP2C19 (0.52) IDO1MAPTCA2ALDH1A1
SCHEMBL5781780 0.73 TAAR1 (0.55) IDO1TAAR1SIRT2PTPN1GSK3B
SCHEMBL13319587 0.73 MAPT (0.53) IDO1MAPTTAAR1BCHEACHE
SCHEMBL25930307 0.73 IDO1 (0.52) IDO1MAPTTAAR1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP disclosed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US disclosed
EP-1187846-A2 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS Schering Aktiengesellschaft (DE) 2002-03-20 EP disclosed
WO-2001000652-A2 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2001-01-04 WO disclosed